ClinicalTrials.gg
Not yet recruitingNCT07858058Updated Oct 5, 2026

The Effect of White and Pink Noise in Patients Undergoing Total Hip and Knee Arthroplasty

An interventional study of White Noise Intervention and Pink Noise Intervention in Arthroplasty, Replacement, Knee, Hip, Postoperative Nausea and Vomiting and Anxiety, sponsored by Ataturk University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Ataturk University · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 5, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
165
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey — 22 open to participants now, 23 under way, none of them phase 3. Postoperative Nausea and Vomiting · Turkey.

Planned enrollment
8th of 71
165 · median 90
Started
2026
with 11 others
No phase
55 of 96
13 open now
Primary completion
2027-03
later than 16 of 22 live
Registered
94th of 96
by date
Lead sponsor
3 of 96
Ataturk University

Among the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, this one is the 8th largest by planned enrollment of the 71 interventional ones that give a count, is one of 12 that started in 2026, is one of 55 with no phase, reaches primary completion later than 16 of the 22 other live ones, and was the 94th registered.

Postoperative Nausea and Vomiting

638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.

Browse Postoperative Nausea and Vomiting studies →

Open to participants now

22 of the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 66 Postoperative Nausea and Vomiting studies recruiting now, 22 (33%) set no upper age limit and 38 (58%) stop at 75 or younger; 15 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to investigate the effects of preoperative white noise and pink noise interventions on sleep quality, anxiety, postoperative pain, nausea, and physiological parameters in patients undergoing elective total hip arthroplasty (THA) or total knee arthroplasty (TKA). A total of 165 adult patients will be randomly allocated into three equal groups: a white noise group, a pink noise group, and a control group (55 participants per group). On the evening prior to surgery (around 10:00 PM), participants in the experimental groups will listen to standardized white noise or pink noise at 45-50 dB for 30 minutes via over-ear, active noise-cancelling headphones. Participants in the control group will receive routine perioperative care without any auditory intervention. Data regarding sleep quality, anxiety levels, pain intensity, nausea, and hemodynamics (blood pressure, heart rate, respiratory rate, and oxygen saturation) will be collected using validated scales and physiological monitoring before and after the intervention as well as in the postoperative period (at 0, 12, and 24 hours).

03

Conditions studied

  • Arthroplasty, Replacement, Knee, Hip
  • Postoperative Nausea and Vomiting
  • Anxiety
  • Postoperative Pain After Arthroscopic Knee Surgery
  • Sleep Quality

Keywords

  • Coloured noise
  • Total knee arthroplasty
  • Total hip arthroplasty
  • Sleep quality
  • Preoperative anxiety
  • Postoperative pain
  • Postoperative nausea
  • Nursing intervention
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for elective primary unilateral total hip or knee arthroplasty
  • Aged 18 years or older
  • (ASA) physical status classification I, II, or III
  • Literate and able to understand, communicate, and independently complete questionnaires in Turkish
  • Intact hearing ability (no self-reported or diagnosed severe hearing loss)
  • Voluntarily agreed to participate in the study and signed written

Exclusion criteria

Exclusion Criteria:

  • Diagnosed psychiatric, cognitive, or neurological disorders that impair communication or scale completion
  • Clinically diagnosed chronic sleep disorders (e.g., severe obstructive sleep apnea, chronic insomnia)
  • Regular use of sedative-hypnotics, anxiolytics, or psychiatric medications within the last month
  • Administration of preoperative sedative or hypnotic premedication on the night before surgery
  • Active ear infection, dermatological lesions, or anatomical deformities preventing the use of over-ear headphones
  • Severe tinnitus, hyperacusis, or hearing aid usage
  • Emergency surgery, bilateral procedures, or revision arthroplasty
  • Known history of substance or alcohol dependence
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
165 participants (estimated)

Study arms

  • Experimental
    White Noise Group

    Participants will listen to standardized white noise at 45-50 dB for 30 minutes via over-ear, active noise-cancelling headphones on the preoperative evening (at 10:00 PM) before elective total hip or knee arthroplasty.

    Behavioral: White Noise Intervention

  • Experimental
    Pink Noise Group

    Participants will listen to standardized pink noise at 45-50 dB for 30 minutes via over-ear, active noise-cancelling headphones on the preoperative evening (at 10:00 PM) before elective total hip or knee arthroplasty.

    Behavioral: Pink Noise Intervention

  • No intervention
    Control Group

    Participants will receive standard routine perioperative care and nursing management without any auditory intervention or headphone application.

Interventions

  • BehavioralWhite Noise Intervention

    Participants will listen to standardized white noise played at a volume of 45-50 dB for 30 minutes using over-ear active noise-cancelling headphones on the preoperative night (at approximately 10:00 PM).

  • BehavioralPink Noise Intervention

    Participants will listen to standardized pink noise played at a volume of 45-50 dB for 30 minutes using over-ear active noise-cancelling headphones on the preoperative night (at approximately 10:00 PM).

06

What researchers measure

Primary outcomes

  1. Preoperative Sleep Quality

    Assessed using the Richard-Campbell Sleep Questionnaire (RCSQ). The scale evaluates depth of sleep, falling asleep latency, awakenings, time spent awake, and overall sleep quality (scores range from 0 to 100 mm, where higher scores represent better sleep quality).

    Time frame: Assessed on the morning of surgery (at approximately 07:00 AM, following the preoperative night intervention).

  2. Preoperative State Anxiety

    Assessed using the State-Trait Anxiety Inventory - State Subscale (STAI-S / STAI Form TX-1). The scale consists of 20 items rated on a 4-point Likert scale (1 = Not at all to 4 = Very much so). Total scores range from 20 to 80, with higher scores reflecting greater levels of acute state anxiety.

    Time frame: Assessed at baseline (pre-intervention, preoperative evening around 21:30) and immediately after the 30-minute intervention (preoperative evening around 22:30).

Secondary outcomes

  1. Systolic and Diastolic Blood Pressure

    Systolic and diastolic blood pressure measured in millimeters of mercury (mmHg) using a calibrated clinical monitor to evaluate autonomic nervous system responses to auditory interventions.

    Time frame: Baseline (preoperative evening, immediately before intervention at approximately 21:30) and immediately post-intervention (approximately 22:30)

  2. Heart Rate

    Heart rate measured in beats per minute (bpm) using a clinical monitor to evaluate autonomic nervous system responses to auditory interventions.

    Time frame: Baseline (preoperative evening, immediately before intervention at approximately 21:30) and immediately post-intervention (approximately 22:30)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Mar 2027, 5 months later.

Of 181 non-industry interventional studies with no phase under Postoperative Nausea and Vomiting, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 5 months is below that.

Counting every sponsor, half of 181 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2026
First posted
Oct 5, 2026
StartEst.
Oct 10, 2026
Primary completionEst.
Mar 15, 2027
CompletionEst.
Mar 15, 2027
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07858058
Lead sponsor
Ataturk University
Responsible party
Mehmet Gunay Uyar (Assistant Professor, Ataturk University) — Principal investigator
First posted
Oct 5, 2026
Start date
Oct 10, 2026 (estimated)
Primary completion
Mar 15, 2027 (estimated)
Completion
Mar 15, 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

Mehmet Günay Uyar, PhD
Contact
mehmet.uyar@erzincan.edu.tr
05543488391
Mehmet Günay Uyar, PhD
principal investigator · Erzincan Binali Yildirim Universitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion